small molecule

OXSORALEN-ULTRA

METHOXSALEN

Loss of exclusivityloss of exclusivity
CompanyBAUSCH HEALTH AMERICAS INC

Drug detail

Brand nameOXSORALEN-ULTRA
Active ingredientMETHOXSALEN
Strength10MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1986
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OXSORALEN-ULTRA patent cliff — loss of exclusivity — | CliffBio